A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 6,497 shares of AMGN stock, worth $2.08 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
6,497
Previous 2,869 126.46%
Holding current value
$2.08 Million
Previous $816 Million 148.86%
% of portfolio
0.58%
Previous 0.29%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$262.75 - $319.31 $953,257 - $1.16 Million
3,628 Added 126.46%
6,497 $2.03 Billion
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $262,685 - $317,095
977 Added 51.64%
2,869 $816 Million
Q4 2023

Feb 09, 2024

BUY
$255.7 - $288.46 $49,861 - $56,249
195 Added 11.49%
1,892 $545 Million
Q3 2023

Nov 08, 2023

BUY
$218.65 - $271.46 $371,049 - $460,667
1,697 New
1,697 $456 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Annis Gardner Whiting Capital Advisors, LLC Portfolio

Follow Annis Gardner Whiting Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Annis Gardner Whiting Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annis Gardner Whiting Capital Advisors, LLC with notifications on news.